(Updated - March 14, 2022 12:55 PM EDT)

Stifel analyst Benjamin Burnett downgraded Nektar Therapeutics (NASDAQ: NKTR) to Hold ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE